Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1195 Cabdf1 Bd1 Inhibitor 1
Novel selective CaBdf1 BD1 inhibitor
More description
DCC1194 Caa0225
Novel specific inhibitor of cathepsin L, effectively inhibiting degradation of LC3-II and GABARAP
More description
DCC1193 Ca-074
Potent and selective inhibitor of cathepsin B
More description
DCC1192 Ca Ix/xii Inhibitor
Selective inhibitor of hCA IX and hCA XII
More description
DCC1191 C5-chem-clip
Novel covalent cross-linker to the SARS-CoV-2 frameshifting element (FSE), directly targeting engagement of the SARS-CoV-2 FSE in cells, dose dependently reducing frameshifting in cells expressing the SARS-CoV-2 FSE, with no significant effect on frameshi
More description
DCC1190 C562-1101
Novel potent inhibitor of botulinum neurotoxin serotype E (BoNT/E)
More description
DCC1189 C48/80
Inducer of mast cell degranulation
More description
DCC1188 C3b Inhibitor Cmp-5
The first C3b-binding complement inhibitor, inhibiting the formation of the membrane attack complex (MAC) by preventing cleavage of C5
More description
DCC1187 C3-005
First-In-Class Inhibitor of the Interaction between Bacterial RNA Polymerase and Sigma Initiation Factor, Affecting the Viability and Toxin Release of Streptococcus pneumoniae
More description
DCC1186 C3001a
Novel selective activator for TREK, against other two-pore domain K (K2P) channels
More description
DCC1185 c1-resveratrol
Novel multi-functional resveratrol derivative for the treatment of atrial fibrillation
More description
DCC1184 C15alkopp
FPP analogue, bearing an alkyne group to allow for post-prenylation protein labeling
More description
DCC1183 C12-pr-spn
Novel broad-spectrum intracellular targeting antibacterial agent, interacting with the 70S ribosome of E. coli and inhibiting its protein synthesis, demonstrating superior clearance of bacteria from the spleen, liver, and kidneys of mice, infected with S.
More description
DCC1182 C10-pr-spn
Novel broad-spectrum intracellular targeting antibacterial agent, interacting with the 70S ribosome of E. coli and inhibiting its protein synthesis, demonstrating superior clearance of bacteria from the spleen, liver, and kidneys of mice, infected with S.
More description
DCC1181 C012 Dihydrochloride
Novel sensitizer of BRAF wild-type melanoma cells to vemurafenib, significantly reducing melanoma cell viability, with limited toxicity for normal human fibroblasts
More description
DCC1180 C000000956
Natural inhibitor of BACE1
More description
DCC1179 C[pro-arg-phe-phe-asn-ala-phe-dpro]
β-Hairpin Octapeptide, acting as a potent mouse melanocortin-4 receptor (mMC4R) antagonist
More description
DCC1178 Bzn-ejj-amide
Novel potent and selective PTP-1B inhibitor
More description
DCC1177 Bz(1,2,4,5)p4
Novel promising spectroscopic probe for inositol 5-phosphatase(s)
More description
DCC1176 Bxl0124
Novel Gemini vitamin D analog, targeting CD44-STAT3 signaling and inhibiting breast cancer invasion
More description
DCC1175 Bw284c51
Highly selective inhibitor of AChE
More description
DCC1174 Bw2258u89
Novel BB2 receptor antagonist. attenuating the feeding responses evoked by exogenous gastrin releasing peptide-29
More description
DCC1173 bvt-2733 Hydrochloride
Selective 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) inhibitor
More description
DCC1172 Bvt-116429
Novel 11β-HSD1 inhibitor
More description
DCC1171 Butylcycloheptyl Prodiginine
Natural inhibitor of microRNA-21, reducing growth of cancer cells
More description
DCC1170 Butafenacil
Potent inducer of anemia
More description
DCC1168 Budralazine
Direct-acting vasodilator with anti-tachycardiac effect
More description
DCC1167 Bucinnazine
Potent and selective agonist of μ-opioid receptor (MOR) with relatively low affinity for the δ-opioid receptor and the κ-opioid receptor
More description
DCC1165 Btzo-4
Negative control for BTZO-1
More description
DCC1164 Btz-n3
Novel effective reversible and noncovalent inhibitor of DprE1.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X